Atlas Trials

Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC

Clinical trial NCT03671265 · UNKNOWN

Trial details

NCT number
NCT03671265
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2018-09-17
Primary completion
2019-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.